12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·9 hours agoMPLT-72.91%PFSA-28.65%
Oncobiologics (NASDAQ:OTLK) Stock Price Expected to Rise, HC Wainwright Analyst SaysMarket Beat·9 hours agoOTLK-24.20%GS-D-0.21%
Outlook Therapeutics Targets Multibillion Dollar Ophthalmology Market With New Drug After FDA Rejectionbenzinga_article·12 hours agoOTLK-24.20%
This General Motors Analyst Turns Bulish; Here Are Top 5 Upgrades For Mondaybenzinga_article·14 hours agoF-C-5.00%F-D+0.33%
Pre-market hot trades in US stocks: Outlook Therapeutics up 8.84% in pre-market; SAP up 4.80% in pre-marketPrice Alert·16 hours agoOTLK-24.20%SAP+6.88%
FDA Approvals and Earnings Beats Propel Specialized US-Listed FirmsGlobal Report·1 day ago, 04:14 AMREPL-11.03%CELC-0.42%
Niche U.S. Equities Face Commercial and Regulatory Tests in Mid-2026Global Report·2 days ago, 04:18 AMAUR+4.37%VSME+6.03%
From Web3 Pivots to AI Robotics Deals: Tracking Capital Shakeups Across U.S. EquitiesGlobal Report·2 days ago, 04:13 AMOTLK-24.20%YYAI-73.51%
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD | OTLK Stock NewsStockTitan·Jul 24 at 05:40 AMOTLK-24.20%
